Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 2, Pages 444
Publisher
MDPI AG
Online
2018-02-20
DOI
10.3390/molecules23020444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preparation of a novel radiotracer targeting the EphB4 receptor via radiofluorination using spiro azetidinium salts as precursor
- (2017) Jens Wiemer et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements
- (2017) Olivia J. Kelada et al. MOLECULAR IMAGING AND BIOLOGY
- Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings
- (2017) Florence Colliez et al. Frontiers in Oncology
- EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer
- (2016) JingHuan Lv et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Gelatin-based Hydrogel Degradation and Tissue Interaction in vivo: Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice
- (2016) Christoph Tondera et al. Theranostics
- Development of indazolylpyrimidine derivatives as high-affine EphB4 receptor ligands and potential PET radiotracers
- (2015) Kristin Ebert et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Validation of functional imaging as a biomarker for radiation treatment response
- (2015) C Jentsch et al. BRITISH JOURNAL OF RADIOLOGY
- EphB4 inhibitor overcome the acquired resistance to cisplatin in melanomas xenograft model
- (2015) Xiaokun Yang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Whole-Body PET/CT Evaluation of Tumor Perfusion Using Generator-Based 62Cu-Ethylglyoxal Bis(Thiosemicarbazonato)Copper(II): Validation by Direct Comparison to 15O-Water in Metastatic Renal Cell Carcinoma
- (2014) J. W. Fletcher et al. JOURNAL OF NUCLEAR MEDICINE
- Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab
- (2013) Irene Guijarro-Muñoz et al. MEDICAL ONCOLOGY
- Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro
- (2013) Bettina Reissenweber et al. MELANOMA RESEARCH
- Protein and non-protein biomarkers in melanoma: a critical update
- (2012) Nadine Tandler et al. AMINO ACIDS
- Radiosynthesis of a 18F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo
- (2012) Torsten Kniess et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth
- (2012) M. A. Abengozar et al. BLOOD
- Fluorine-18 Radiolabeling and Radiopharmacological Characterization of a Benzodioxolylpyrimidine-based Radiotracer Targeting the Receptor Tyrosine Kinase EphB4
- (2012) Constantin Mamat et al. ChemMedChem
- The Role of Angiogenesis Inhibitors in the Management of Melanoma
- (2012) Kamarul Ahmad Zaki et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Irradiation affects cellular properties and Eph receptor expression in human melanoma cells
- (2012) Birgit Mosch et al. Cell Adhesion & Migration
- Therapy for metastatic melanoma: an overview and update
- (2011) Glen M Boyle Expert Review of Anticancer Therapy
- Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand
- (2011) Raphael Rutkowski et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
- (2011) Roy S Herbst et al. LANCET
- Time-Course Imaging of Therapeutic Functional Tumor Vascular Normalization by Antiangiogenic Agents
- (2011) Q. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel EphB4 Monoclonal Antibodies Modulate Angiogenesis and Inhibit Tumor Growth
- (2010) Valery Krasnoperov et al. AMERICAN JOURNAL OF PATHOLOGY
- The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
- (2010) Georg Martiny-Baron et al. ANGIOGENESIS
- EphB4 Promotes Site-Specific Metastatic Tumor Cell Dissemination by Interacting with Endothelial Cell–Expressed EphrinB2
- (2010) Mélanie Héroult et al. MOLECULAR CANCER RESEARCH
- Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
- (2010) Suphansa Sawamiphak et al. NATURE
- Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
- (2010) Yingdi Wang et al. NATURE
- VEGF and ephrin-B2: a bloody duo
- (2010) Stéphane Germain et al. NATURE MEDICINE
- The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand
- (2010) Nai-Ying Yang et al. Pigment Cell & Melanoma Research
- Heterogeneity of the Tumor Vasculature
- (2010) Janice Nagy et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
- (2010) Birgit Mosch et al. Journal of Oncology
- Why are tumour blood vessels abnormal and why is it important to know?
- (2009) J A Nagy et al. BRITISH JOURNAL OF CANCER
- Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
- (2009) Carolyn J. Anderson et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
- (2009) Sara Rockwell et al. CURRENT MOLECULAR MEDICINE
- Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: Correlation with clinical parameters and outcome
- (2009) Roger Mouawad et al. EUROPEAN JOURNAL OF CANCER
- Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
- (2009) Janice M. Mehnert et al. HUMAN PATHOLOGY
- Lymphangiogenesis and cancer metastasis
- (2009) Viviane Mumprecht et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies
- (2008) Axel Grothey et al. CANCER JOURNAL
- Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis
- (2008) Y. H. Kim et al. DEVELOPMENT
- Tumor lymphangiogenesis and melanoma metastasis
- (2008) Matthias Rinderknecht et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor†
- (2008) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tumor Blood Flow Measured by PET Dynamic Imaging of First-Pass 18F-FDG Uptake: A Comparison with 15O-Labeled Water-Measured Blood Flow
- (2008) N. A. Mullani et al. JOURNAL OF NUCLEAR MEDICINE
- Lymphatic Endothelial Cells, Lymphedematous Lymphangiogenesis, and Molecular Control of Edema Formation
- (2008) Rui-Cheng Ji Lymphatic Research and Biology
- Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins
- (2008) Nathan E. Basken et al. NUCLEAR MEDICINE AND BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started